Hobson R W, Weiss D G, Fields W S, Goldstone J, Moore W S, Towne J B, Wright C B
Veterans Affairs Cooperative Studies Program Coordinating Center, Perry Point, Md.
N Engl J Med. 1993 Jan 28;328(4):221-7. doi: 10.1056/NEJM199301283280401.
The efficacy of carotid endarterectomy in patients with asymptomatic carotid stenosis has not been confirmed in randomized clinical trials, despite the widespread use of operative intervention in such patients.
We conducted a multicenter clinical trial at 11 Veterans Affairs medical centers to determine the effect of carotid endarterectomy on the combined incidence of transient ischemic attack, transient monocular blindness, and stroke. We studied 444 men with asymptomatic carotid stenosis shown arteriographically to reduce the diameter of the arterial lumen by 50 percent or more. The patients were randomly assigned to optimal medical treatment including antiplatelet medication (aspirin) plus carotid endarterectomy (the surgical group; 211 patients) or optimal medical treatment alone (the medical group; 233 patients). All the patients at each center were followed independently by a vascular surgeon and a neurologist for a mean of 47.9 months.
The combined incidence of ipsilateral neurologic events was 8.0 percent in the surgical group and 20.6 percent in the medical group (P < 0.001), giving a relative risk (for the surgical group vs. the medical group) of 0.38 (95 percent confidence interval, 0.22 to 0.67). The incidence of ipsilateral stroke alone was 4.7 percent in the surgical group and 9.4 percent in the medical group. An analysis of stroke and death combined within the first 30 postoperative days showed no significant differences. Nor were there significant differences between groups in an analysis of all strokes and deaths (surgical, 41.2 percent; medical, 44.2 percent; relative risk, 0.92; 95 percent confidence interval, 0.69 to 1.22). Overall mortality, including postoperative deaths, was primarily due to coronary atherosclerosis.
Carotid endarterectomy reduced the overall incidence of ipsilateral neurologic events in a selected group of male patients with asymptomatic carotid stenosis. We did not find a significant influence of carotid endarterectomy on the combined incidence of stroke and death, but because of the size of our sample, a modest effect could not be excluded.
尽管无症状性颈动脉狭窄患者广泛接受手术干预,但随机临床试验尚未证实颈动脉内膜切除术对此类患者的疗效。
我们在11家退伍军人事务医疗中心进行了一项多中心临床试验,以确定颈动脉内膜切除术对短暂性脑缺血发作、短暂性单眼失明和中风联合发病率的影响。我们研究了444例经动脉造影显示动脉管腔直径缩小50%或更多的无症状性颈动脉狭窄男性患者。患者被随机分配至最佳药物治疗组,包括抗血小板药物(阿司匹林)加颈动脉内膜切除术(手术组;211例患者)或仅接受最佳药物治疗组(药物组;233例患者)。每个中心的所有患者均由血管外科医生和神经科医生独立随访,平均随访47.9个月。
手术组同侧神经事件的联合发病率为8.0%,药物组为20.6%(P<0.001),相对风险(手术组与药物组相比)为0.38(95%置信区间,0.22至0.67)。仅同侧中风的发病率在手术组为4.7%,在药物组为9.4%。术后30天内中风和死亡合并分析显示无显著差异。在所有中风和死亡分析中,两组之间也无显著差异(手术组,41.2%;药物组,44.2%;相对风险,0.92;95%置信区间,0.69至1.22)。总体死亡率,包括术后死亡,主要归因于冠状动脉粥样硬化。
颈动脉内膜切除术降低了一组特定的无症状性颈动脉狭窄男性患者同侧神经事件的总体发病率。我们未发现颈动脉内膜切除术对中风和死亡联合发病率有显著影响,但由于我们样本量的原因,不能排除有适度影响的可能性。